Brief: Laurus Labs Approves Investment Up To EUR 9.8 Million In KRKA Pharma
30/04/2026 11:13
April 30 (Reuters) - Laurus Labs Ltd LAUL.NS: LAURUS LABS - APPROVES INVESTMENT UP TO EUR 9.8 MILLION IN KRKA PHARMA PRIVATE LIMITED LAURUS LABS - KRKA D.D. NOVO MESTO, SLOVENIA (CO-VENTURER) TO INVEST ABOUT EUR 10.2 MILLION IN KRKA PHARMA Source text: ID:nNSE58vwvh Further company coverage: LAUL.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Laurus Labs
See all newsIndia's Laurus Labs hits record high as Q2 profit more than doubles
Brief: Laurus Labs Declares Dividend Of 1 Rupee Per Share
Brief: Laurus Labs Invests 1.08 Billion Rupees Into KRKA Pharma Via Rights Issue
Brief: Laurus Labs Invests 120.96 Million Rupees In Kurnool Renewables Via Rights Issue
Four Indian stocks to be added, three removed from key global index in MSCI's August rejig